• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Suboptimal Peak Inspiratory Flow in Patients Hospitalized for COPD Exacerbation: Prevalence and Predictive Factors.慢性阻塞性肺疾病加重住院患者的吸气峰流速不佳:患病率及预测因素。
J Aerosol Med Pulm Drug Deliv. 2024 Oct;37(5):225-231. doi: 10.1089/jamp.2024.0002. Epub 2024 Jun 19.
2
Peak Inspiratory Flow and Inhaler Prescription Strategies in a Specialized COPD Clinical Program: A Real-World Observational Study.专业慢性阻塞性肺疾病临床项目中的吸气峰流量与吸入器处方策略:一项真实世界观察性研究
Chest. 2025 Mar;167(3):736-745. doi: 10.1016/j.chest.2024.09.031. Epub 2024 Oct 9.
3
An in-hospital intervention to reduce the proportion of misused inhalers at hospital discharge among patients with COPD: a non-randomised intervention study.一项院内干预措施以降低 COPD 患者出院时误用吸入器的比例:一项非随机干预研究。
Swiss Med Wkly. 2024 Apr 4;154:3394. doi: 10.57187/s.3394.
4
Predictive machine learning algorithm for COPD exacerbations using a digital inhaler with integrated sensors.使用带有集成传感器的数字吸入器的慢性阻塞性肺疾病(COPD)急性加重预测机器学习算法。
BMJ Open Respir Res. 2025 May 12;12(1):e002577. doi: 10.1136/bmjresp-2024-002577.
5
Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.吸入装置在哮喘和慢性阻塞性气道疾病中的有效性比较:文献系统评价
Health Technol Assess. 2001;5(26):1-149. doi: 10.3310/hta5260.
6
Tiotropium versus placebo for chronic obstructive pulmonary disease.噻托溴铵与安慰剂治疗慢性阻塞性肺疾病的比较
Cochrane Database Syst Rev. 2012 Jul 11(7):CD009285. doi: 10.1002/14651858.CD009285.pub2.
7
Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.联合使用皮质类固醇和长效β2受体激动剂的单一吸入器与长效β2受体激动剂治疗慢性阻塞性肺疾病的比较
Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD006829. doi: 10.1002/14651858.CD006829.pub2.
8
Bronchodilators delivered by nebuliser versus pMDI with spacer or DPI for exacerbations of COPD.通过雾化器与使用储雾罐的压力定量吸入器或干粉吸入器给药的支气管扩张剂用于慢性阻塞性肺疾病急性加重期的治疗
Cochrane Database Syst Rev. 2016 Aug 29;2016(8):CD011826. doi: 10.1002/14651858.CD011826.pub2.
9
Inhaled corticosteroids with combination inhaled long-acting beta2-agonists and long-acting muscarinic antagonists for chronic obstructive pulmonary disease.吸入性皮质类固醇联合吸入长效β2-激动剂和长效抗胆碱能药物治疗慢性阻塞性肺疾病。
Cochrane Database Syst Rev. 2023 Dec 6;12(12):CD011600. doi: 10.1002/14651858.CD011600.pub3.
10
Predictors of Suboptimal Peak Inspiratory Flow in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Clinical Practice.临床实践中慢性阻塞性肺疾病急性加重患者吸气峰流速未达最佳水平的预测因素
Tuberc Respir Dis (Seoul). 2025 Jul;88(3):516-525. doi: 10.4046/trd.2024.0154. Epub 2025 Mar 6.

本文引用的文献

1
High Prevalence of Suboptimal Peak Inspiratory Flow in Hospitalized Patients With COPD: A Real-world Study.慢性阻塞性肺疾病住院患者吸气峰流速未达最佳水平的高患病率:一项真实世界研究
Chronic Obstr Pulm Dis. 2022 Jul 29;9(3):427-438. doi: 10.15326/jcopdf.2022.0291.
2
Measuring Peak Inspiratory Flow in Patients with Chronic Obstructive Pulmonary Disease.测量慢性阻塞性肺疾病患者的吸气峰值流量。
Int J Chron Obstruct Pulmon Dis. 2022 Jan 6;17:79-92. doi: 10.2147/COPD.S319511. eCollection 2022.
3
Prevalence and Associated Factors of Suboptimal Daily Peak Inspiratory Flow and Technique Misuse of Dry Powder Inhalers in Outpatients with Stable Chronic Airway Diseases.稳定期慢性气道疾病门诊患者每日最大吸气峰流量未达最佳水平及干粉吸入器技术使用不当的患病率和相关因素
Int J Chron Obstruct Pulmon Dis. 2021 Jun 23;16:1913-1924. doi: 10.2147/COPD.S311178. eCollection 2021.
4
Spanish COPD Guidelines (GesEPOC) 2021: Updated Pharmacological treatment of stable COPD.《2021年西班牙慢性阻塞性肺疾病指南(GesEPOC):稳定期慢性阻塞性肺疾病的药物治疗更新》
Arch Bronconeumol. 2022 Jan;58(1):69-81. doi: 10.1016/j.arbres.2021.03.005. Epub 2021 Mar 17.
5
Evaluation of Suboptimal Peak Inspiratory Flow in Patients with Stable COPD.稳定期慢性阻塞性肺疾病患者吸气峰流速未达最佳水平的评估
J Clin Med. 2020 Dec 5;9(12):3949. doi: 10.3390/jcm9123949.
6
Inappropriate Peak Inspiratory Flow Rate with Dry Powder Inhaler in Chronic Obstructive Pulmonary Disease.干粉吸入器在慢性阻塞性肺疾病中不适当的吸气峰流速。
Sci Rep. 2020 Apr 29;10(1):7271. doi: 10.1038/s41598-020-64235-6.
7
Prevalence and predictors of suboptimal peak inspiratory flow rate in COPD patients.COPD 患者中未达最佳吸气峰流速的流行率及预测因素。
Eur J Pharm Sci. 2020 Apr 30;147:105298. doi: 10.1016/j.ejps.2020.105298. Epub 2020 Mar 6.
8
The role of inspiratory flow in selection and use of inhaled therapy for patients with chronic obstructive pulmonary disease.吸气流量在慢性阻塞性肺疾病患者吸入治疗选择和使用中的作用。
Respir Med. 2020 Jan;161:105857. doi: 10.1016/j.rmed.2019.105857. Epub 2019 Dec 28.
9
Nebulized Versus Dry Powder Long-Acting Muscarinic Antagonist Bronchodilators in Patients With COPD and Suboptimal Peak Inspiratory Flow Rate.慢性阻塞性肺疾病(COPD)且吸气峰流速未达最佳值患者中雾化吸入与干粉吸入长效毒蕈碱拮抗剂支气管扩张剂的比较
Chronic Obstr Pulm Dis. 2019 Oct 23;6(4):321-31. doi: 10.15326/jcopdf.6.4.2019.0137.
10
Spirometry Measurement of Peak Inspiratory Flow Identifies Suboptimal Use of Dry Powder Inhalers in Ambulatory Patients with COPD.肺活量测定法测量吸气峰流量可识别慢性阻塞性肺疾病门诊患者干粉吸入器的使用不当情况。
Chronic Obstr Pulm Dis. 2019 Jul 24;6(3):246-255. doi: 10.15326/jcopdf.6.3.2018.0163.

慢性阻塞性肺疾病加重住院患者的吸气峰流速不佳:患病率及预测因素。

Suboptimal Peak Inspiratory Flow in Patients Hospitalized for COPD Exacerbation: Prevalence and Predictive Factors.

机构信息

Pulmonology Department, Álvaro Cunqueiro University Hospital, Vigo, Spain.

NeumoVigo I + I Research Group, Galicia Sur Health Research Institute (IISGS), Vigo, Spain.

出版信息

J Aerosol Med Pulm Drug Deliv. 2024 Oct;37(5):225-231. doi: 10.1089/jamp.2024.0002. Epub 2024 Jun 19.

DOI:10.1089/jamp.2024.0002
PMID:39388689
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11502629/
Abstract

Despite the importance of an adequate peak inspiratory flow (PIF) during inhaled therapy in patients with COPD, the available evidence in patients with severe exacerbations and their evolution after admission is limited. We conducted this study to evaluate the PIF during an exacerbation, its variability, and predictors of suboptimal PIF. A prospective study that included patients admitted for COPD exacerbation. Clinical, demographic, and functional variables were recorded. Using the In-Check DIAL G16, PIF without resistance (PIF-nr) and that obtained by simulating the resistance of the patients' usual inhalers (PIF) were determined within the first 48 hours of admission and prior to discharge; also assessed during a stable phase in a subgroup of patients. The results were compared and, through a multivariate study, the factors related to a suboptimal PIF were analyzed. A total of 137 patients were included; 27% were women and the mean age was 69.4 ± 9.8 years. Moreover, 30.8% of the participants with dry powder inhalers had a suboptimal PIF at admission and it was independently associated with female sex (odds ratio [OR] = 8.635; 95% confidence interval [CI] [2.007, 37.152]; < 0.01) and forced expiratory volume in the 1st second (FEV1) (OR = 0.997; 95% CI: [0.995, 0.999]; = 0.04). At discharge, suboptimal PIF reduced to 17% ( < 0.01). PIF-nr increased from the time of admission to the stable phase. One third of COPD patients admitted with a severe exacerbation had a suboptimal PIF, being female sex and lower FEV1 independent predictors. PIF-nr improved progressively after the exacerbation.

摘要

尽管在 COPD 患者中,吸入治疗时的适当峰值吸气流量(PIF)非常重要,但严重加重期患者的可用证据以及入院后的演变情况有限。我们进行这项研究,以评估加重期时的 PIF、其变异性以及 PIF 不理想的预测因素。

这是一项前瞻性研究,纳入了因 COPD 加重而入院的患者。记录了临床、人口统计学和功能变量。在入院后 48 小时内和出院前,使用 In-Check DIAL G16 测定无阻力(PIF-nr)和模拟患者常用吸入器阻力时的 PIF(PIF);在患者亚组的稳定期也进行了评估。比较了结果,并通过多变量研究分析了与 PIF 不理想相关的因素。

共纳入 137 例患者,其中 27%为女性,平均年龄为 69.4±9.8 岁。此外,30.8%使用干粉吸入器的患者入院时 PIF 不理想,且与女性性别独立相关(比值比[OR] = 8.635;95%置信区间[CI] [2.007, 37.152]; < 0.01)和第一秒用力呼气量(FEV1)(OR = 0.997;95%CI:[0.995, 0.999]; < 0.01)。出院时,PIF 不理想的比例降至 17%( < 0.01)。PIF-nr 从入院时到稳定期逐渐增加。

三分之一因严重加重而入院的 COPD 患者 PIF 不理想,女性性别和较低的 FEV1 是独立预测因素。加重后 PIF-nr 逐渐改善。